Aurélie Courtin
Genetic Technologies (Australia)(AU)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Synthesis and biological activity, Cancer therapeutics and mechanisms, Computational Drug Discovery Methods, Estrogen and related hormone effects
Most-Cited Works
- SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.(2003)
- → Glucocorticoid receptor and breast cancer(2011)101 cited
- → Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells(2009)68 cited
- → Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation(2014)67 cited
- → Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2(2018)65 cited
- → Androgens Repress the Expression of the Angiogenesis Inhibitor Thrombospondin-1 in Normal and Neoplastic Prostate(2005)62 cited
- → CHK1 Inhibition Synergizes with Gemcitabine Initially by Destabilizing the DNA Replication Apparatus